Fedha

Hisa unazofuatilia
INCY:NASDAQ
Incyte Corp
US$ 121.35
-1.50%
(-1.85) Siku 1
US$ 121.35
0.00% (0.00)
Baada ya saa
Imefungwa: 30 Sep, 16:00:00 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya INCY...
Fungua
US$ 123.00
Juu
US$ 124.23
Chini
US$ 121.03
Mtaji wa soko
24.60B
Wastani wa kiasi cha mauzo
1.41M
Kiasi cha mauzo ya hisa
162.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
15.46
Juu kwa wiki 52
US$ 132.58
Chini kwa wiki 52
US$ 82.82
EPS
US$ 7.85
Beta
0.77
Hisa za wawekezaji
202.70M
Idadi ya wafanyakazi
elfu 3
Fungua
US$ 123.00
Juu
US$ 124.23
Chini
US$ 121.03
Mtaji wa soko
24.60B
Wastani wa kiasi cha mauzo
1.41M
Kiasi cha mauzo ya hisa
162.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
15.46
Juu kwa wiki 52
US$ 132.58
Chini kwa wiki 52
US$ 82.82
EPS
US$ 7.85
Beta
0.77
Hisa za wawekezaji
202.70M
Idadi ya wafanyakazi
elfu 3
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Kuhusu Incyte Corp
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 2.84
Lilianzishwa2002
Makao makuuWilmington, Delaware, Marekani
Sekta-
Tovutiincyte.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 21 waliotoa ukadiriaji wa hisa kwa INCY katika miezi 3 iliyopita
Nunua
Nunua
11
Shikilia
10
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 21 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya INCY katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 121.35
US$ 155.00 (+27.73%)
Wastani
US$ 131.05 (+7.99%)
Chini kabisa
US$ 104.00 (-14.30%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$ 152.00
+25.3%
09/29/2026
Jessica Fye
J.P. Morgan
Hold
Maintained
US$ 123.00
+1.4%
09/28/2026
Jeffrey Walch
Bernstein
Hold
Maintained
US$ 104.00
-14.3%
09/25/2026
Brian Abrahams
RBC Capital
Hold
Maintained
US$ 109.00
-10.2%
09/22/2026
Evan Seigerman
BMO Capital
Hold
Maintained
US$ 130.00
+7.1%
08/31/2026
John Newman
Canaccord Genuity
Buy
Initiated
US$ 152.00
+25.3%
08/21/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/19/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
US$ 130.00
+7.1%
08/17/2026
Derek Archila
Wells Fargo
Hold
Maintained
US$ 116.00
-4.4%
08/06/2026
Salim Syed
Mizuho Securities
Buy
Maintained
US$ 137.00
+12.9%
08/03/2026
Andrew Berens
Leerink Partners
Buy
Maintained
US$ 155.00
+27.7%
08/03/2026
Srikripa Devarakonda
Truist Financial
Hold
Reiterated
-
-
07/29/2026
Salveen Richter
Goldman Sachs
Hold
Maintained
US$ 118.00
-2.8%
07/29/2026
Ashwani Verma
UBS
Hold
Maintained
US$ 113.00
-6.9%
07/28/2026
Michael Schmidt
Guggenheim
Buy
Maintained
US$ 150.00
+23.6%
07/28/2026
Judah Frommer
Morgan Stanley
Hold
Maintained
US$ 119.00
-1.9%
07/29/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
US$ 140.00
+15.4%
07/28/2026
Etzer Darout
Barclays
Buy
Reiterated
US$ 139.00
+14.5%
07/28/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
US$ 145.00
+19.5%
07/28/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$ 120.00
-1.1%
07/28/2026
Marc Frahm
TD Cowen
Buy
Maintained
US$ 138.00
+13.7%
07/28/2026
Unknown Analyst
Bernstein
Hold
Maintained
-
-
06/01/2026
Unknown Analyst
J.P. Morgan
Hold
Maintained
US$ 105.00
-13.5%
05/20/2026
Unknown Analyst
Guggenheim
Buy
Maintained
US$ 130.00
+7.1%
05/04/2026
Unknown Analyst
Argus Research
Buy
Maintained
US$ 115.00
-5.2%
04/30/2026
Faisal Khurshid
Jefferies
Hold
Downgraded
US$ 94.00
-22.5%
03/15/2026
Unknown Analyst
Evercore ISI
Hold
Maintained
US$ 110.00
-9.4%
03/05/2026
Ripoti ya mwisho
28 Jul 2026
Kipindi cha Kifedha
Robo2 2026
Mapato kwa kila hisa dhidi ya makadirio (USD)
US$ 3.09 / US$ 2.15
+43.95%umepitiliza
Mapato dhidi ya makadirio (USD)
1.67B / 1.49B
+12.39%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
1.37B
1.51B
1.27B
1.67B
Gharama ya bidhaa zilizouzwa
605.58M
732.55M
620.43M
621.91M
Gharama ya mapato
605.58M
732.55M
620.43M
621.91M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
328.29M
388.96M
327.06M
350.72M
Gharama ya uendeshaji
328.29M
388.96M
327.06M
350.72M
Jumla ya gharama za uendeshaji
933.87M
1.12B
947.49M
972.63M
Mapato ya uendeshaji
432.11M
385.32M
325.19M
701.41M
Mapato mengine yasiyo ya uendeshaji
3.25M
4.22M
1.75M
5.26M
EBT ikijumuisha vipengee visivyo vya kawaida
482.31M
389.94M
343.60M
751.51M
EBT bila kujumuisha vipengee visivyo vya kawaida
461.55M
419.71M
360.06M
744.21M
Gharama ya kodi ya mapato
58.14M
90.66M
40.27M
165.91M
Kiwango cha kodi kinachotumika
12.05%
23.25%
11.72%
22.08%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
424.17M
299.28M
303.33M
585.60M
Kiwango cha faida halisi
31.05%
19.86%
23.83%
34.98%
Mapato kwa kila hisa
2.26
1.80
1.81
3.09
Mapato ya riba na uwekezaji
26.78M
30.75M
33.69M
38.12M
Gharama ya riba
elfu -592.00
elfu -582.00
elfu -569.00
elfu -582.00
Jumla ya gharama halisi za riba
26.19M
30.17M
33.12M
37.54M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
456.13M
409.30M
348.99M
727.89M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google